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It remains unclear how interleukin-21 receptor
(IL-21R) contributes to type 1 diabetes. Here
we have shown that dendritic cells (DCs) in the
pancreas required IL-21R not for antigen uptake,
but to acquire the chemokine receptor CCR7 and
migrate into the draining lymph node. Consequently,
less antigen, major histocompatibility complex
(MHC) class II, and CD86 was provided to autoreac-
tive effector cells in Il21r/ mice, impairing CD4+
T cell activation, CD40:CD40L interactions, and
pancreatic infiltration by autoreactive T cells. CD40
crosslinking restored defective CD4+ cell expansion
and CD4 independently expanded autoreactive
CD8+ cells, but CD8+ cells still required CD4+ cells
to reach the pancreas and induce diabetes. Diabetes
induction by transferred T cells required IL-21R-
sufficient host antigen-presenting cells. Transferring
IL-21R-sufficient DCs broke diabetes resistance in
Il21r/ mice. We conclude that IL-21R controls
both antigen transport byDCs and the crucial beacon
function of CD4+ cells for autoreactive CD8+ cells to
reach the islets.
INTRODUCTION
Interleukin-21 (IL-21), a pleiotropic common gamma (gc) chain
cytokine, is produced mainly by activated CD4+ T cells and NK
T cells (Spolski and Leonard, 2008), but low amounts of IL-21
mRNA have also been found in B cells, macrophages, and
dendritic cells (Elsaesser et al., 2009). The IL-21R is expressed
on T cells, natural killer (NK) cells, NK T cells, B cells, dendritic
cells (DCs), and macrophages as well as on nonhematopoietic
cells, including keratinocytes and fibroblasts (Spolski and
Leonard, 2008). IL-21 has crucial roles in the development,
proliferation, survival, and differentiation of multiple cell lineages
of both the innate and adaptive immune systems (Rochman
et al., 2009).
Interactions between IL-21 and IL-21R play a critical role in
chronic viral infection (Elsaesser et al., 2009) and allergic skin1060 Immunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc.inflammation (Jin et al., 2009) but are also implicated in autoim-
mune diseases like systemic lupus erythematosus, multiple
sclerosis, rheumatoid arthritis, and type 1 diabetes (Spolski
and Leonard, 2008). Autoimmune or type 1 diabetes (T1D) is
a predominantly T cell-mediated disease in which insulin-
producing pancreatic cells are selectively destroyed (Van Belle
et al., 2011). Genetic linkage studies support an association of
the region containing the IL-2 and IL-21 genes on human chro-
mosome 4q27 with T1D (Todd et al., 2007) and polymorphic
variants of IL-21 and its receptor have been associated with
genetic susceptibility to T1D (Asano et al., 2007). In mice, the
Idd3 locus contains the genes encoding both IL-21 and IL-2.
IL-21 mRNA increases during diabetes development (King
et al., 2004; Sutherland et al., 2009) and IL-21R is critically
required for diabetes development in the nonobese diabetic
(NOD) model (Datta and Sarvetnick, 2008; Spolski et al., 2008;
Sutherland et al., 2009). Dissecting how IL-21R contributes to
diabetogenesis can help to rationally evaluate whether IL-21
blockade is useful and how to place it optimally as a potential
intervention in T1D.
We used the virus-induced human insulin promoter-lympho-
cytic choriomeningitis model (Ins-LCMV) model for T1D, in addi-
tion to the NOD and adoptive transfer models, to define the
cellular interactions that depend on IL-21R signals independent
of the genetic background and T1D susceptibility allele interfer-
ence. We have revealed that IL-21R-mediated signals promote
efficient migration of pancreatic DCs carrying antigen (Ag) to
the draining LN. Without IL-21R, the subsequent autoreactive
CD4+ T cell response is truncated at the CD40:CD40L
level, causing impaired pancreatic infiltration of autoreactive
CD8+ T cells.RESULTS
IL-21R Is Required for Pancreatic Infiltration and
Autoimmune Diabetes in the RIP-LCMV Model
IL-21R is required for diabetes development in the spontaneous
NOD model of diabetes (Sutherland et al., 2009). To exclude the
interference of genetic deletion of Il21r with other T1D suscepti-
bility genes, we dissected the role of IL-21R in a rapid and
aggressive virus-induced diabetes model (Martinic et al., 2007;
von Herrath et al., 1994). Transgenic human insulin promoter
(Ins)-lymphocytic choriomeningitis virus (LCMV)-nucleoprotein
Figure 1. Pancreatic Infiltration by T Cells and Induction of Diabetes Depend on IL-21R
(A) Diabetes was induced by inoculation with LCMV of Il21r+/+, Il21r+/, and Il21r/ littermate NOD-NP mice.
(B–D) Viable cell numbers, divided by 106, of CD4+ (top) and CD8+ (bottom) T cells, determined in spleen (B), pancreatic LN (C), and pancreas (D) on day (d) 0, 4, 7,
or 30 a.i. of Il21r+/+ or Il21r/ NOD-NP mice. For frequencies, see Figure S1. Symbols, line, and error bars reflect individual values, group mean, and SEM,
respectively.
(E) Pancreatic islet infiltration by CD4+ and CD8+ T cells in Il21r+/+ and Il21r/ NOD-NP mice on days 7 and 25 a.i.
(F) Representative pictures of islet infiltration by CD4+ (top) and CD8+ (bottom) T cells in Il21r+/+ and Il21r/ NOD-NP mice by immunohistochemistry. Red, CD4
(top) or CD8 (bottom); blue, insulin.
Statistical significance in each panel: ns not significant, *p < 0.05, **p < 0.01, ***p < 0.001.
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IL-21 Receptor Controls Insulitic Infiltration(NP) NOD mice (NOD-NP) mice, expressing NP specifically
in pancreatic b cells and the thymus, develop diabetes 8
to 14 days after inoculation (a.i.) with LCMV in a CD8+ T cell-
dependent manner.
Il21r+/+ NOD-NP mice (n = 11) rapidly became hyperglycemic
(2 consecutive readings > 250 mg/dl) and remained diabetic
with 100% incidence by day 10 a.i. (Figure 1A), whereas 75%
of Il21r+/ NOD-NP mice (9 out of 12) developed diabetes.
In contrast, less than 20% of Il21r/ NOD-NP mice (4 out
of 20) developed permanent diabetes, and this with later
onset than in Il21r+/+ mice (day 12 versus 8–10 a.i.). Another
fraction of less than 20% of Il21r/ mice became transiently
hyperglycemic and all other Il21r/ NOD-NP mice remained
normoglycemic. These data show that IL-21R is critical for
diabetes development in the virus-induced model of diabetes
with a gene dosage effect, as in the spontaneous model
(Sutherland et al., 2009).
IL-21 is required to control chronic but not acute LCMV
viral infection (Elsaesser et al., 2009; Fro¨hlich et al., 2009;
Yi et al., 2009). Here, the acute infection by LCMV Armstrong
used to initiate diabetes resulted in a similar increase in spleen
CD4+ and CD8+ T cells on days 4, 7, and 30 a.i. of Il21r+/+ and
Il21r/ NOD and NOD-NP (numbers, Figure 1B; frequencies,
Figure S1A available online). Of note, because the severediabetes in Il21r+/+ NOD-NP mice caused severe metabolic
consequences, the day 30 measurements were done in
NOD mice. Numbers and frequencies of CD4+ and CD8+
T cells in pancreatic LN on days 4 or 7 a.i. were similar in
Il21r+/+ and Il21r/ mice (Figures 1C and S1B). Pancreata
from Il21r/ NOD-NP mice had lower CD4+ and CD8+ T cell
numbers and frequencies (Figures 1D and S1C) and showed
less insulitis (Figures 1E and 1F) than Il21r+/+ littermates.
Pancreata from Il21r/ NOD-NP mice also contained more
islets (data not shown) and only had a limited degree of peri-
insulitis andmild T cell infiltration by day 7, whereas Il21r+/+ litter-
mates already showed severe infiltration by day 7, including
completely destroyed islets and scars (Figures 1E and 1F).
By day 25, pancreatic infiltration of CD8+ and CD4+ T cells had
exacerbated in Il21r+/+ mice, whereas CD8+ T cell infiltration
did not worsen in Il21r/ pancreata.
We had previously observed strong expression of CXCR3
on LCMV-specific CD8+ T cells as well as high amounts of
the CXCR3 chemokine IP-10 in the pancreas of LCMV-infected
RIP-LCMV mice (Christen et al., 2003) or b cell-specific IL-21
transgenic (Tg) mice (Sutherland et al., 2009). Here, CXCR3
expression was not qualitatively different on CD4+ (Figures
S1D–S1F) or CD8+ (Figures S1G–S1I) T cells in the spleen,
pancreatic LN, and pancreata of Il21r+/+ and Il21r/ NOD-NPImmunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc. 1061
Figure 2. Reduced Numbers, but Not Func-
tionality, of Autoantigen-Specific CD8+ T
Cells in Il21r–/– Mice
(A–C) Autoreactive CD8+ T cells, enumerated as
viable np396-404/Db pentamer+CD8+CD19CD4
T cells in spleen (A), pancreatic LN (B), and
pancreas (C) of Il21r+/+ and Il21r/ NOD-NP
littermates at indicated time points.
(D) Auto-antigen-specific IFN-g production in
spleen, shown as percent IFN-g+ cells of viable
CD4CD8+ T cell gate after in vitro restimulation
with np394-404 peptide.
(E–G) Degranulation of viable CD8+CD4 T cells
from spleen (E), pancreatic LN (F), and pancreas
(G), assessed by surface expression of CD107a
(LAMP-1) upon in vitro restimulation with
np396-404 peptide, and shown as percent
CD107a+ of CD8+ T cells.
(A–G) Symbols represent individual numbers, red
lines and error bars the mean ± SEM.
(H) Helpless assay. CD8 T cells, purified from
Il21r+/+ (white bars) or Il21r/ (black bars) NOD
spleens day 30 a.i., were restimulated in vitro for
6 days on gp(33-41) or np(396-404)-peptide-
pulsed macrophages (np-pulsed Mf, top row;
gp-pulsed Mf, bottom row) without or with exog-
enous IL-2 as indicated. Shown are the group
averages ± SEM of the calculated expansion of
pentamer+CD8+ T cells (left) or IFN-g+CD8+ T cells
(right). No statistical difference by t test.
Statistical significance in each panel: ns, not
significant; *p < 0.05, **p < 0.01.
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IL-21 Receptor Controls Insulitic Infiltrationmice on days 4 and 7 a.i. However, in the Il21r/ NOD-NP
pancreas, the lower total numbers of CD4+ and CD8+
T cells (Figure 1D) translated in lower absolute numbers of
CXCR3+CD4+ and CXCR3+CD8+ T cells (data not shown).
Taken together, these results demonstrate that IL-21R defi-
ciency protects against diabetes induction in a rapid, aggressive
virus-induced diabetes model. Moreover, pancreatic infiltration,
but not CXCR3 acquisition, by CD4+ and CD8+ T cells depends
on IL-21R signals.Reduced Numbers of Autoantigen-Specific CD8+ T Cells
in Il21r–/– Mice
Next, we assessed the expansion of autoantigen-specific
CD8+ T cells in Il21r+/+ or Il21r/ NOD-NP mice. Enumeration
by MHC-peptide pentamer staining revealed a slower and less
pronounced accrual of LCMV-np396-404-specific CD8+ T cells
in Il21r/ NOD-NP mice (Figure 2A). By day 4, np396-404-
specific CD8+ T cell numbers had increased 2-fold in the spleen
of Il21r+/+ NOD-NP mice, but not in the spleen of Il21r/ litter-
mates. By day 7, this number had increased to 11-fold in
Il21r+/+ spleens and only 4-fold in Il21r/ spleens. Similarly,
np396-404-specific CD8+ T cell numbers were lower in the
pancreatic LN and pancreas (Figures 2B and 2C) of day 7-in-
fected Il21r/ NOD-NP mice. On the other hand, a similar1062 Immunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc.fraction of CD8+ T cells in the spleen,
pancreatic LN, and pancreas of Il21r/
NOD-NP mice was capable of produc-
ing interferon-g (IFN-g) (Figure 2D) orto degranulate (Figures 2E–2G) upon autoantigen-specific
stimulation.
CD8+ T Cells Are Not ‘‘Helpless’’ in the Il21r–/– Mice
We next examined whether CD8+ T cells had a ‘‘helpless’’
phenotype in Il21r/ mice by measuring their capacity for
secondary expansion by the ex vivo restimulation assay
(Janssen et al., 2003) in which Ag-specific CD8+ T cells from
‘‘memory’’ mice are quantified before and after an in vitro Ag-
specific challenge. Impaired in vitro expansion can reveal the
absence of adequate CD4+ T cell help during priming in vivo.
Enumeration of np396-404-specific CD8+ T cells by pentamer
staining and assessment of cytokine production revealed similar
frequencies and function in spleens of day 30-infected Il21r+/+
and Il21r/ NOD mice (data not shown). Next, purified ‘‘day
30’’ CD8+ T cells were restimulated in vitro by peptide-pulsed
macrophages and NP-specific CD8+ T cells were counted on
day 6. Both gp33-41- and np396-404-specific CD8+ T cells
from Il21r/ LCMV-memory NOD mice expanded normally
upon secondary challenge (Figure 2H). Provision of IL-2, known
to overcome defective secondary expansion (Schoenberger
et al., 1998), increased the expansion of LCMV-specific CD8+
T cells from both Il21r+/+ and Il21r/ mice. We conclude that
secondary expansion of CD8+ T cells from Il21r/mice is intact.
Immunity
IL-21 Receptor Controls Insulitic InfiltrationCD8+ T Cells Require IL-21R-Sufficient CD4+ T Cells
to Cause Diabetes
We next dissected whether CD4+ or CD8+ T cells depended on
IL-21R expression for diabetes transfer to NOD scid recipients.
As expected (Miller et al., 1988; Sutherland et al., 2009), transfer
of IL-21R-sufficient CD4+ and CD8+ T cells caused severe
pancreatic infiltration and diabetes within 4 weeks (Figures 3A
and 3B). In contrast, IL-21R-deficient CD4+ and CD8+ T cells
did not cause insulitis or diabetes. Interestingly, IL-21R-deficient
CD8+ T cells entered the pancreatic islets and caused diabetes
only when IL-21R-sufficient CD4+ T cells were cotransferred.
Nevertheless, IL-21R-deficient CD8+ T cells trail their IL-21R-
sufficient counterparts, either because of an intrinsically lower
potency or because (autoreactive) CD8+ T cells obtained from
diabetic NOD mice are already primed, whereas those from
Il21r/ NOD mice need priming in the host after cotransfer
with IL-21R-sufficient CD4+ T cells. Strikingly, cotransfers
containing IL-21R-deficient CD4+ T cells never caused insulitis
or diabetes, indicating that CD8+ T cells require the presence
of IL-21R-sufficient CD4+ T cells. Defective cell survival or
reconstitution of NOD scid lymphoid space does not explain
these observations, as we found equivalent numbers of CD4+
or CD8+ T cells in spleen or pancreatic LN of all recipients
(Figure 3C). We conclude that the main T cell defect in Il21r/
NOD mice is within the CD4+ population and less in the CD8+
T cell population.
IL-21 Supports In Vitro Survival and Expansion of NOD
CD4+ T Cells
We next addressed how IL-21 signals influence the expansion
and survival of CD4+ T cells upon TCR stimulation. Similar
numbers were recovered from IL-21R-sufficient or -deficient
CD4+ T cell cultures after 4 days of anti-CD3 stimulation
in vitro (Figure 3D). IL-21 supplementation increased the number
of recovered CD4+ T cells by almost 10-fold and allowed better
CD4+ T cell survival, as determined by Annexin V and viability
dye (Figures 3E and 3F). Similar results were obtained with
more IL-21 (500 ng/ml) or with Il21r/ NOD T cell-depleted
splenocytes (TdS), or by blocking IL-21 with IL-21R-Fc fusion
protein, respectively (data not shown).
Activation of CD4+ T cells temporarily downregulates CD127
and upregulates CD25 (Dooms et al., 2007), which can render
T cells susceptible to Fas-mediated activation-induced cell
death (AICD) (Van Parijs et al., 1997). IL-21 supplementation
reduced the surface expression of CD127 even more (Figure 3G)
but also reduced the CD25hi fraction of CD4+ T cells (Figure 3H).
Also, IL-21R-deficient CD4+ T cells are indeed more sensitive to
activation-induced cell death (AICD) induction than are IL-21R-
sufficient CD4+ T cells (Figure 3I). These data indicate that
IL-21 supports CD4+ T cell expansion by protecting cells against
cell death.
Lack of Diabetes in the Il21r–/– NOD Mice Is Not due
to Enhanced Regulatory T Cell Activity
We and others have shown that regulatory T (Treg) cell numbers
are not increased in the lymphoid compartments of Il21r/NOD
mice (Spolski et al., 2008; Sutherland et al., 2009), but IL-21
can overcome Treg cell suppression in vitro and in vivo (Clough
et al., 2008). Our in vitro suppression assay with carboxyfluores-cein diacetate succinimidyl ester (CFSE)-labeled CD4+CD25
T cells as responder T (Tresp) cells confirmed that addition of
IL-21 abolished suppression of IL-21R-sufficient CD4+ Tresp
cells by Treg cells (Figures 3J and 3K). Tresp cells required
IL-21R for optimal resistance to suppression by Treg cells
(Figure 3J), but Treg cells also required IL-21R for optimal
suppressive capacity. Crossover experiments showed that
provision of IL-21 to Treg cells alone, but not to Tresp cells,
enhanced the suppressive capacity of Treg cells. So, Treg cells
profit from the presence of IL-21, but the effect on the Tresp
cells dominates and IL-21R-deficient Treg cells are less
potent in vitro.
Next, we addressed the contribution of Treg cells in vivo.
First, depletion of CD4+CD25+Foxp3+ Treg cells by cyclophos-
phamide (CY) treatment rapidly induced diabetes in Il21r+/+
NOD mice (Brode et al., 2006), but Il21r/ NOD mice remained
normoglycemic (Figure 3L), indicating that Treg cell function
is not responsible for diabetes resistance in Il21r/ NOD mice.
Second, the Foxp3+ Treg cell fraction of CD4+ T cells declined
sooner in Il21r/ than in Il21r+/+ NOD-NP mice during virus-
induced diabetes (Figure 3M), indicating that diabetes resistance
is not caused by increased Treg cell frequencies. We conclude
that diabetes resistance in the Il21r/ mice is not caused by
enhanced Treg cell numbers or function.
Reduced CD40:CD40L Interactions in Il21r–/– Mice
CD4+ T cells depended on IL-21R to transfer diabetes and
are required for diabetes induction in RIP-LCMV-NP mice on
the NOD (Figure S2A) and BALB/c background (von Herrath
et al., 1994). Because CD40L:CD40 interactions are important
for CD4+ T cell help (Janssen et al., 2003) and critical in
autoimmune diabetes (Eshima et al., 2003; Homann et al.,
2002), we hypothesized that APC:CD4+ T cell crosstalk via
CD40:CD40L interactions was inadequate in Il21r/ mice.
We found a lower frequency of CD4+ T cells expressing
surface and intracellular CD40L during diabetes development
in Il21r/ mice: in the spleen in the virus-induced NOD-NP
model (Figures 4A–4F) and in the spleen and pancreatic LN
in the spontaneous NOD model (Figures S2C and S2D).
However, IL-21R-deficient CD4+ T cells can sufficiently express
CD40L under optimal stimulation conditions in vitro (Figure S2E).
This suggests that the reduced amount of CD40L in vivo reflect
an impaired stimulation of CD4+ T cells in Il21r/ NOD and
NOD-NP mice.
A possible consequence of defective CD40L expression is
an interruption of the positive intercellular feedback loop
between T cell-derived CD40L and CD40 on the Ag-presenting
cells (APCs) such as DCs (Quezada et al., 2004) in the Il21r/
mice. To test this, we stimulated CD40 on APCs by a single
dose of agonistic anti-CD40 (clone FGK45) on day 5 a.i. This
indeed rapidly precipitated diabetes in all Il21r/ NOD-NP
mice (Figure 4G), but only when CD4+ T cells were present. In
the spontaneous model, CD40 ligation slightly accelerated
disease onset in Il21r+/+ NOD mice, but not in Il21r/ NOD
mice (Figure S2F). It is possible that the differential outcome in
the two models is explained by effects of the LCMV infection,
for example a reduction in Treg cell amounts or increased inflam-
mation. However, Treg cell depletion during CD40 ligation did
not cause diabetes or even insulitis in Il21r/ NOD miceImmunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc. 1063
Figure 3. IL-21R Is Critically Required on CD4+ T Cells for Diabetes Induction
(A) 63 106 CD4+ and 33 106 CD8+ T cells from diabetic Il21r+/+ or age-matched Il21r/NODmice were cotransferred into 6-week-old NOD scidmice. Shown is
the diabetes incidence, followed after transfer (a.t.), n = 4–5 mice per group, three experiments.
(B) Pancreatic infiltration, scored in cotransfer recipients and shown as percent of islets with indicated degree (top) of infiltration by CD4+ (left) and CD8+ (right)
cells. n > 70 islets per group.
(C) Numbers of CD4+ andCD8+ T cells recovered from spleen and pancreatic LN of NOD scid recipients at diabetes onset or study’s end. Color codes as in (A). No
statistical difference by t test.
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IL-21 Receptor Controls Insulitic Infiltration(Figure S2G), supporting the idea that Treg cells do not play
a major role in the diabetes resistance of Il21r/ mice. CD40
ligation combined with multiple low-dose streptozotocin
(MLD-STZ)-induced limited b cell death readily caused diabetes
in the Il21r/ NOD mice (Figure S2H), suggesting that the
different impact of CD40 crosslinking in NOD-NP and NOD
models is attributable to differences in stringency.
CD40 ligation interfered with the numbers of CD4+ and auto-
reactive CD8+ T cells (Figures 4H–4J). Initially, CD40 ligation
slightly increased CD4+ T cell frequencies and decreased NP-
specific CD8+ T cell frequencies, but by day 22 a.i., CD40 ligation
had increased the numbers of LCMV-NP-specific CD8+ T cells
in blood, spleen, and pancreatic LN. This accumulation of NP-
specific CD8+ T cells was independent of CD4+ T cells but
required the presence of CD4+ T cells for the NP-specific CD8+
T cells to enter the pancreatic islets. Taken together, bypassing
the CD40:CD40L defect in Il21r/mice helps to expand autoan-
tigen-specific CD8+ T cells independent of CD4+ help but does
not circumvent the need for CD4+ T cells to facilitate pancreatic
infiltration and diabetes development.
APCs from Il21r–/– Mice Express Less MHC Class II and
Costimulatory Molecules
To test whether the reduced fraction of CD4+ T cells expressing
CD40L reflected a lower number or functional capacity of APCs
in Il21r/ mice, we first determined the frequencies of different
APC subsets in the virus-induced NOD-NP model. Surprisingly,
the frequency of DC and DC subsets was higher in spleen,
pancreatic LN, and pancreas in Il21r/ versus Il21r+/+ NOD-NP
mice on day 4 a.i. (Figures 5A–5C). Specifically, frequencies
of DC subsets with immune-stimulatory capacity, such as
myeloid DCs (mDCs) and CD8a+ DCs, were higher in spleens
of Il21r/ mice on days 4 and 7 a.i., whereas the frequency of
plasmacytoid DCs (pDCs), instrumental in viral infections but
also associated with tolerogenic responses (Saxena et al.,
2007), did not change.
Proficient CD4+ T cell stimulation depends on T cell receptor
(TCR) triggering by Ag presented on MHC class II together with
costimulatory signals. Interestingly, MHC class II expression
in pancreata of Il21r/ mice was about 30%–50% of that in(D–I) IL-21R signals enhance in vitro expansion and protect CD4+ T cells against AI
stimulated for 4 days with 0.25 mg/ml anti-CD3 and NOD T cell-depleted splenoc
Shown are the viable CD4+ T cell numbers (D), percent Annexin Vneg CD4+ T cell
CD25 (H).
(G) Surface expression of CD127 on viable CD4+ T cells before (tinted) or after ac
murine (rm)IL-21.
(I) AICD assay, showing the percent of dead cells 36 hr after secondary stimulat
(J and K) Treg and Tresp cells depend on IL-21R for optimal suppression and es
(J) CFSE-labeled Thy1a allellically marked Il21r+/+ or Il21r/ CD4+CD25 NOD
without or with Thy1b allellically marked Il21r+/+ or Il21r/CD4+CD25+NODT (Tre
are overlays of CFSE dilution profiles (CD4+Thy1a+Thy1b viable cell gate), repr
(K) Division index of responder T cells (cf. J), reflecting the average number of ce
representative of three experiments.
(L) Il21r/ NODmice are resistant to CY-induced diabetes. Treg cells were deple
age.
(M) Treg cells are not increased in Il21r/ NOD-NP mice. Foxp3 frequency in th
diabetes induction by inoculation with LCMV.
Data shown in (C), (D)–(F), (H), (I), (K), and (L) show group mean with standard devi
and SEM, respectively.
Statistical significance in each panel: ns, not significant, *p < 0.05, **p < 0.01, ***Il21r+/+ NOD-NP mice (Figure 5E), suggesting a functional APC
defect in the pancreas (see below). In spleen of Il21r/NOD-NP
mice, less mDCs, CD8a+ DCs, B cells, and macrophages coex-
pressed MHCII and CD86 (Figure 5D) and macrophages failed
to upregulate CD80 by day 4 a.i. (Figure 5F). APC subsets
expressed high amount of MHC class I on day 4 a.i. and this
was unaffected by IL-21R deficiency (data not shown). Addition-
ally, we found less CCR7-expressing MHC class II+ CD11c+ DCs
in the pancreatic LN and pancreas of Il21r/ NOD-NP mice,
despite normal amounts in spleen (Figures 5G–5I). This is
important because mature DCs express CCR7 that can act as
a key regulator governing the trafficking of DCs into lymphatic
vessels (Ohl et al., 2004).
In conclusion, APCs in Il21r/ NOD-NP mice are abundant,
but the reduced expression of key molecules suggests a defect
in APC function.
Pancreatic DCs Depend on IL-21R Signals to Migrate
to the Draining LN
We assessed the functional consequences of reduced expres-
sion of MHC class II, CD86, and CCR7 by using intrapancreatic
injection of fluorochrome-labeled ovalbumin (Fluo-OVA) as
a source of soluble protein. This revealed a reduced capacity
of IL-21R-deficient APCs to shuttle Ag from the pancreas to
the pancreatic LN (Figure 6). First, in the pancreatic LN of
Il21r+/+ NOD-NP mice, we found that DCs (15%–20%),
especially CD8a+ DCs (25%–30%) and mDCs (15%–20%), had
the highest fractions of Fluo-OVA+ cells, whereas less than
5% of the B cells and macrophages contained Fluo-OVA.
Importantly, the Fluo-OVA+ fractions in mDCs, CD8a+ DCs,
B cells, and macrophages were reduced in the LN of Il21r/
NOD-NP mice. Second, the numbers and frequency of all
Fluo-OVA+ DCs and DC subsets in the draining LN were dimin-
ished in the pancreatic LN of Il21r/ NOD-NP mice. Third, we
observed a different constitution of the Fluo-OVA+ DC popula-
tions: in Il21r+/+ mice, mDCs were represented most, followed
by CD8a+ DCs and a minimal fraction of pDCs, whereas in
Il21r/ NOD-NP mice, Fluo-OVA+ DCs contained mostly
mDCs, but the pDC fraction was larger than the CD8a+ DC
fraction, suggesting that antigen (Ag) presentation could be ofCD.CD4+CD25 T cells from Il21r+/+ (+/+) or Il21r/ (/) NODmicewere in vitro
ytes in the absence (white bars) or presence (black bars) of 100 ng/ml rmIL-21.
s (E), percent viable CD4+ T cells (F), and fraction expressing high amounts of
tivation with (solid) or without (dashed line) addition of 100 ng/ml recombinant
ion with anti-CD3.
cape from suppression, respectively.
responder (Tresp) cells were stimulated for 4 days with 0.25 mg/ml anti-CD3
g) cells at 1:2 Treg:Tresp ratios and 200 ng/ml rmIL-21, where indicated. Shown
esentative of three experiments. CK, cytokine.
ll divisions that the responding cells underwent (i.e., ignores undivided peak),
ted by treatment with cyclophospamide (CY, 200 mg/kg) in week 11 and 13 of
e CD4+ T cell population in spleen of NOD-NP mice on days 0, 4, and 7 after
ation; in (M), symbols, line, and error bars reflect individual values, group mean,
p < 0.001.
Immunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc. 1065
Figure 4. CD40 Stimulation Mobilizes Autoantigen-Specific CD8+ T Cells and Overcomes Diabetes Resistance in Il21r–/– NOD-NP Mice
(A–F) Diabetes was induced in Il21r+/+ (white circles) or Il21r/ (black circles) NOD-NP mice. On days 4 and 7, surface (A–C) or intracellular (D–F) expression of
CD40L by CD4+ T cells was determined, gated as shown in Figure S2B. Symbols represent the percent of CD40L+ in the viable CD4+ T cell gate in individual
spleen (A, D), pancreatic LN (B, E), and pancreas (C, F). Symbols, line, and error bars reflect individual values, group mean, and SEM, respectively.
(G) Diabetes was induced in Il21r/ NOD-NP mice treated with PBS (none), CD40 agonistic mAb (100 mg FGK45 i.v. on day 5), GK1.5 mAb (CD4+ depletion,
250 mg i.p. on days 3, 1, and +1), or both. Shown is the average blood glycemia (in mg/dl) per group.
(H) Frequencies of CD4+ T cells (top) and np(396-404)/Db pentamer+ cells in the CD8+CD4CD19 lymphocyte gate (bottom) on day 8 a.i. in blood of Il21r/
NOD-NP mice treated as indicated (also see G). Dashed line represents a naive Il21r/ NOD-NP mouse.
(I) Number of IFN-g-producing CD8+ T cells on day 22 a.i. in blood, spleen, and pancreatic LN (PanLN) of mice treated as indicated (also see G) after in vitro
restimulation with np396-404 peptide (no IL-2) for 5 hr in the presence of Brefeldin A.
Symbols, line, and error bars in (H) and (I) reflect individual values, mean, and SEM, respectively.
(J) Immunostaining of pancreas sections for insulin (blue) and CD4+ (red, left) or CD8+ (red, right). Displayed pictures represent predominant infiltration grade
in >60 islets per group.
Statistical significance in each panel: ns, not significant; *p < 0.05, **p < 0.01.
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Fluo-OVA+ DCs that arrive in the pancreatic LN express CCR7
in Il21r+/+ and Il21r/ NOD-NP mice, so it is likely that the few
Fluo-OVA+ DCs that arrive in the Il21r/ LN also used CCR7
for migration to the LN.1066 Immunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc.Similarly, in the spontaneous NOD model, fewer Fluo-OVA+
DCs were detected in the pancreatic LN of Il21r/ NOD mice
(Figures S3A and S3B). Ag was presented in the Il21r+/+
pancreatic LN uniquely by the CD11cintMHCIIhi DC subset and
not by CD11chiMHCIIint DC, as shown before (Turley et al.,
Figure 5. Reduced Acquisition of MHCII, CD80, CD86, and CCR7 by APCs in Il21r–/– Mice
(A) Ag-presenting cell subsets were determined in spleens of Il21r+/+ (white circles) or Il21r/ (black circles) NOD-NP mice a.i., shown as fraction of cells: mDC
(viable CD11b+CD11c+DX5CD3B220CD8a), CD8a+ DC (viable CD8a+CD11c+DX5CD3B220CD11b), pDC (viable B220+CD11c+DX5CD3B220
CD11bCD8a), B cell (viable B220+DX5CD3CD8aCD11bCD11c), or macrophage (viable CD11b+ DX5CD3B220CD8aCD11c).
(B and C) Dendritic cells in pancreatic LN (B) and pancreas (C) on day 4 a.i., shown as viable CD11c+DX5CD3 fraction of cells.
(D) Frequencies of MHC class II+ CD86+ cells within the indicated DC population in spleens of Il21r+/+ (white circles) or Il21r/ (black circles) NOD-NP mice. nd,
not detected.
(E) Fraction of MHC class II-expressing cells within the pancreas on day 4 a.i.
(F) Overlays of MHC class II (top), CD80 (B7.1, middle), and CD86 (B7.2, bottom) expression in indicated cell populations in spleens of naive Il21r+/+ (shaded area),
day 4-infected Il21r+/+ (dotted line), or Il21r/ (solid red line) NOD-NP mice.
(G–I) CCR7 expression on DCs in NOD-NP mice on day 4 a.i.
(G) Histogram overlay (top) of CCR7 expression in MHCII+CD11chi cells in spleen. Vertical dashed line indicates cut-off for CCR7hi. Individual data (bottom) of
CCR7hi fraction in MHCII+CD11chi gate.
(H and I) Expression of CCR7 versus MHC class II on day 4 a.i., gated on CD11c+ cells in pancreatic LN (H) or pancreas (I).
(H) Shown are representative contour plots (top) and individual data per group (bottom). Values in plots reflect percent of cells in gate (CCR7hiMHCII+ in
CD11c+ gate).
(I) Shown are contour plots with numbers reflecting the percentages in respective quadrants. Value in parentheses reflects percent of CCR7+ within the
MHCII+CD11c+ subpopulation.
Symbols, line, and error bars reflect individual values, group mean, and SEM, respectively. Statistical significance in each panel: ns, not significant; *p < 0.05,
**p < 0.01.
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CD11cintMHCIIhi DCs in pLN expressed CCR7, consistent
with a recent migration to the LN. In contrast, the pancreatic
LN DCs in Il21r/ NOD not only contained a lower fraction
of CD11cintMHCIIhi cells, but this subset also barely trans-
ported injected Ag (Figure S3B, right column). So, pancreatic
Ags are inefficiently transported to the draining LN in Il21r/
mice.Normal Ag Uptake but Defective CCR7 Acquisition
after Ag Uptake by Il21r–/– Pancreatic DCs
Both inferior Ag uptake and defective acquisition of CCR7
could explain the impaired Ag transport in Il21r/ mice. We
first confirmed a similar in vitro endocytic capacity in
CD11chiMHCIIint and CD11cintMHCIIhi DC subsets (Vermaelen
et al., 2001) and showed that it was independent of IL-21R
signals (Figures S3D–S3F). Also in vivo, a comparable fractionImmunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc. 1067
Figure 6. Pancreatic DCs Need IL-21R Signals for Acquisition of CCR7 and Ag Shuttling to the Pancreatic LN
(A) Setup for Ag-shuttling experiment in the virus-induced NOD-NP model.
(B) Fluo-OVA content in pancreatic LN cell subsets, 24 hr after Fluo-OVA injection in the pancreas. Representative histograms (top: Il21r+/+ dashed line, Il21r/
red solid line) and percent (bottom) of Fluo-OVA signal in viable MHCII+ myeloid DCs (mDC: CD11c+CD11b+mPDCA-1CD8aCD3CD19), CD8a+ DCs
(CD11c+CD8a+mPDCA-1CD11bCD3CD19), plasmacytoid DCs (pDC: CD11c+mPDCA-1+CD11bCD8aCD3CD19), B cells (CD19+CD3CD11c
CD8amPDCA-1CD11b), or macrophages (Mf: CD11b+CD3CD19CD11cCD8amPDCA-1).
(C) Number (top) and frequency of total cells (bottom) of CD11c+Fluo-OVA+MHCII+ DCs and DC subsets in pancreatic LNs of Il21r+/+ or Il21r/ NOD-NP mice,
24 hr after injection in the pancreas. DC subsets identified as in (B).
(D) Percent ofmDC, CD8a+ DCs, and pDC of all viable CD11c+Fluo-OVA+ (CD3CD19) cells in pancreatic LN of Il21r+/+ or Il21r/NOD-NPmice, 12 or 24 hr after
injection in the pancreas.
(E) CCR7 expression on total Fluo-OVA+CD11c+ DCs in the pancreatic LN of Il21r+/+ or Il21r/ NOD-NP mice, 24 hr after injection in the pancreas.
(F) Expression of CCR7 versus MHC class II, gated on Fluo-OVA+ total CD11c+ DCs in the pancreas of Il21r+/+ or Il21r/ NOD-NP mice, 12 hr (top) or 24 hr
(bottom) after Fluo-OVA injection in the pancreas. Numbers within plots reflect the percent of cells within the Fluo-OVA+CD11c+ gate. Numbers in parentheses
denote the percent of CCR7+ cells within the MHCII+Fluo-OVA+CD11c+ gate. Right column: histogram overlays of CCR7 expression, gated on the
Fluo-OVA+CD11c+ population.
Shown are pooled pancreas samples from one representative out of three experiments, each with three mice per genotype and per time point.
Bar graphs reflect mean with SEM. Statistical significance in each panel: ns, not significant; *p < 0.05.
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Il21r/ NOD mice, but fewer pancreatic DCs acquired CCR7
upon uptake of the Ag in Il21r/ NODmice (Figure S3C, bottom
panel). Moreover, Fluo-OVA+ pancreatic DCs in Il21r/
NOD-NP mice were strongly impaired in their ability to
upregulate MHC class II and acquire CCR7 (Figure 6F and
data not shown). Taken together, we showed that impaired
expression of MHC class II and CCR7 by DCs in the pancreas
after Ag uptake leads to defective Ag presentation in the
pancreatic LN of Il21r/ mice.1068 Immunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc.IL-21R-Sufficient DCs Repair the Defect in Il21r–/– Mice
We then wanted to link the functional DC defect
to inadequate T cell stimulation and diabetogenic responses
in Il21r/ mice. First, transferring IL-21R-sufficient DCs
overcame diabetes resistance in Il21r/ NOD-NP mice (Fig-
ure 7A). Second, IL-21R-sufficient T cells were less potent at
inducing diabetes in Il21r/ hosts than in Il21r+/+ hosts
rendered T cell deficient by irradiation (Figure 7B), indicating
that an Ag-presenting population lacking IL-21R is less
efficient at driving T cell responses. Third, we transferred
Figure 7. Il21r+/+ DCs and DC Stimulation Repair the Defect in Il21r–/– Mice
(A) Diabetes was induced in Il21r+/+ or Il21r/ NOD-NP mice and 1 3 106 Il21r+/+ CD11c+ cells were injected. Shown is the average with SEM blood glycemia
(in mg/dl) per group, n = 5–6 per group.
(B) T cells (53 106) from diabetic Il21r+/+ or age-matched Il21r/NODmice were transferred into 8- to 12-week-old irradiated (IRR) Il21r+/+ or Il21r/NODmice
as indicated. Shown is the diabetes incidence per group, n = 3–5 per group.
(C) Ag-specific CD4+ T cell stimulatory capacity of dendritic cells from pancreatic LNs of Il21r+/+ or Il21r/ NOD. CFSE-labeled purified BDC2.5 CD4+ T cells
(1 3 104) were cocultured with Il21r+/+ or Il21r/ NOD DCs (2 3 103 CD11c+CD3CD19DX5) and BDC2.5 mimotope (YVRPLWVRME; 0.5 mg/ml) for 4 days.
Shown are histogram overlays (half offset) of CFSE dilution in CD4+ T cells cocultured with Il21r+/+ (top) or Il21r/ (bottom) DCs.
(D) Expansion of BDC2.5 CD4+ TCR transgenic T cells. CFSE-labeled Il21r+/+ or Il21r/ BDC2.5 CD4+ TCR transgenic T cells (10 3 106) were transferred into
Il21r+/+ or Il21r/NODmice in the presence or absence of agonistic anti-CD40. On day 7, pancreatic LNwere harvested. Shown are representative CFSE dilution
profiles and percent of CFSE-diluted (CFSEdim) cells (gated on viable BDC2.5-tetramer+ CD4+CD8CD90+ cells), n = 3 per group.
Statistical significance in each panel: ns, not significant; *p < 0.05, **p < 0.01.
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hosts and found that CD4+ T cell expansion is impaired
in Il21r/ hosts, unless DCs are stimulated by CD40
crosslinking (Figure 7D). T cell:DC coculture experiments
revealed no intrinsic defect in IL-21R-deficient DCs to
stimulate T cells (Figure 7C). Of note, transferred Il21r+/+
CD4+ T cells expand better than Il21r/ CD4+ T cells in vivo
(Figure 7D). These data support a model in which DCs rely
on IL-21R signals to eventually present Ag to T cells for
stimulation.DISCUSSION
In this study we report three main findings on the immune
response in T1D: (1) after Ag uptake, pancreatic DCs depend
on IL-21R signals to acquire CCR7 and MHC class II for
migration to the draining LN; (2) as a result, CD4+ T cell function
including expression of CD40L is impaired and CD4+ T cells
in Il21r/ mice fail to provide assistance to CD8+ T cells to
infiltrate pancreatic islets; and (3) crosslinking CD40 in Il21r/
mice improves expansion of autoantigen-specific CD8+ T cellsImmunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc. 1069
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are still required as a ‘‘beacon’’ for autoreactive CD8+ cells to
enter the islets.
The strongest non-MHC-linked locus associated with the
autoimmune diabetic phenotype in the NOD mouse is the Idd3
locus, which contains the genes encoding both IL-21 and IL-2
(Denny et al., 1997). Contamination with diabetes-susceptibility
gene variants from founder strains (e.g., C57BL/6) would unlikely
explain the diabetes resistance in Il21r/ NOD mice, because
we now show that IL-21R deficiency also protects in a toxin-
induced model and in the virus-induced RIP-LCMV model,
both mostly independent of diabetes-resistance gene variants
on various genetic backgrounds (Martinic et al., 2007; von
Herrath et al., 1994). Also, several labs have independently
generated Il21r/ NOD strains, all of which are diabetes resis-
tant. Two of these studies used a standard mating approach
(Spolski et al., 2008; Sutherland et al., 2009), and a third study
used marker-assisted mating (Datta and Sarvetnick, 2008).
Il21r/NODmice are claimed to have a defect in homeostatic
T cell proliferation needed for NOD autoimmunity (King et al.,
2004), but we and others found comparable baseline lympho-
cyte counts and Il21r/ splenocytes did not transfer diabetes
to immunodeficient NOD scid recipients, a model dependent
on lymphopenia-driven cell expansion (Spolski et al., 2008;
Sutherland et al., 2009). Here, we have also shown that (1)
purified CD4+ and CD8+ T cells both had normal homeostatic
expansion in NOD scid recipients, and (2) no lymphopenia-
driven homeostatic expansion precedes diabetes in the virus-
induced or the MLD-STZ-induced model (Kantwerk-Funke
et al., 1991; von Herrath et al., 1994).
Although entry of CD8+ T cells into pancreatic islets
was impaired in Il21r/ mice, T cell transfers indicated that
CD4+ T cells critically and CD8+ T cells partially depend on
IL-21R expression. Mechanistically, we ruled out an important
contribution of Treg cells to the diabetes resistance in Il21r/
mice because of (1) normal Treg cell numbers in Il21r/ NOD
mice (Spolski et al., 2008; Sutherland et al., 2009), (2)
the (in vitro) requirement for IL-21R on Treg cells for optimal
function, (3) lower Treg cell frequencies in Il21r/ mice in
the virus-induced model, and (4) failure of in vivo Treg cell
depletion to precipitate diabetes in Il21r/ NOD mice, even
with simultaneousCD40 ligation. Yet, IL-21 supported expansion
of CD4+ T cells in vivo and in vitro and IL-21R-deficient CD4+
T cells were more susceptible to AICD. Moreover, reduced
CD40L expression in Il21r/ NOD and NOD-NP mice reflects
fewer recently activated CD4+ T cells (Chattopadhyay et al.,
2005) and is a consequence of a primary defect of insufficient
Ag presentation by APCs.
It was shown that DCs capture and shuttle self-antigens to
the pancreatic lymph node (Turley et al., 2003). Ablation of
CD11b+CD11c+ DCs prevents T cell activation, insulitis, and
CD4+ T cell-mediated diabetes (Saxena et al., 2007), whereas
expansion of DC populations by Flt3-ligand treatment can
accelerate T1D (Van Belle et al., 2010). In vitro, IL-21R signaling
is not important for DC:T cell interaction because Il21r/ CD4+
T cells could acquire CD40L upon optimal TCR triggering andwe
confirm that Il21r/ DCs support normal proliferation and
cytokine secretion by T cells (Jin et al., 2009). But in vivo, we
found reduced coexpression of MHC class II (signal 1) and1070 Immunity 36, 1060–1072, June 29, 2012 ª2012 Elsevier Inc.CD86 (signal 2) on Il21r/ mDCs, CD8a+ DCs, B cells, and
macrophages during diabetes induction, and pancreatic MHCII+
DCs in Il21r/ mice inadequately acquired CCR7 to migrate
out of the pancreas and transport Ag to the draining LNs,
despite a normal capacity to take up Ag in vitro and in vivo. It
is known that mobilization of DCs requires expression of CCR7
(Ohl et al., 2004). This ‘‘pancreas exit’’ defect might also explain
the larger DC fraction found in the Il21r/ pancreas. Further-
more, transfer of IL-21R-sufficient DCs overcame diabetes
resistance in the Il21r/ mice, whereas IL-21R-sufficient
T cells failed to induce diabetes in Il21r/mice. So, we conclude
that IL-21R is required for pancreatic Ag transport by DCs to
sufficiently prime CD4+ T cells in the draining LN.
The resulting reduced CD40L+ fraction of CD4+ T cells
also interferes with the positive-feedback loop that allows
CD40-expressing APCs to become competent to drive CD8+
T cell responses (Quezada et al., 2004; Schoenberger et al.,
1998). CD40 crosslinking in vivo to bypass insufficient triggers
from CD4+ back to APCs restored defective CD4+ T cell
expansion in Il21r/ mice. CD40 crosslinking also rapidly
induced diabetes in Il21r/ NOD-NP mice, which still required
the presence of CD4+ T cells, but in the spontaneous NOD
model, CD40 ligation alone was insufficient to induce diabetes,
even when Treg cells were depleted from the Il21r/ NOD
mice. The difference might be explained by the fact that viral
infection in the NOD-NP model might set the threshold for
development of T1D quite a bit lower, for example by providing
direct TLR triggers, which in conjunction with CD40 can
‘‘license’’ DCs (Quezada et al., 2004). Indeed, inducing limited
b cell death during CD40 crosslinking rapidly induced diabetes
in Il21r/NODmice, perhaps because of involvement of pattern
recognition receptors (PRR) such as TLR7 and TLR9 that sense
host RNA, DNA, and RNA- or DNA-associated proteins. Our data
could also help to explain why IL-21R is dispensable in
experimental autoimmune encephalomyelitis (EAE) autoimmu-
nity: EAE induction requires injections with complete Freund’s
adjuvant (CFA), which contains Mycobacterium tuberculosis,
a potential trigger of Toll-like receptor 2 (TLR2), TLR4, and
TLR9 (Bafica et al., 2005).
Our data show that the defective CD8+ T cell infiltration in
the pancreas of Il21r/ mice is not due to insufficient presence
of DCs in the pancreas or failure of CD8+ cells to expand,
produce inflammatory cytokines, or acquire CXCR3 in the
periphery. Il21r/ CD8+ T cells also did not exhibit a general
helpless phenotype (Janssen et al., 2003) because (1) memory
CD8+ T cell numbers were normal, in line with data by others
(Elsaesser et al., 2009), (2) secondary expansion was unaffected,
and (3) diabetes induction by CD40 ligation still required the
presence of CD4+ T cells.
Autoimmune diabetes is initiated and perpetuated by
continuous presentation of b cell Ags to autoreactive T cells,
an event predominantly occurring in the pancreatic lymph
nodes (Kurts et al., 1996). Primed autoreactive T cells then
travel to the pancreas to destroy b cells, thereby releasing
more Ags. We have shown here that IL-21 signals play a pivotal
role in the diabetogenic process, and we mechanistically map-
ped this to several crucial checkpoints. Il21r/ DCs took up
Ag normally in the pancreas, but subsequently failed to acquire
CCR7, impeding their migration to the pancreatic draining LN.
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and 2 (from CD86), this led to suboptimal CD4+ stimulation in the
LN. Subsequently, a defective CD40L:CD40 interaction
constrained the positive feedback that CD4+ T cells normally
provide to DCs. Insufficiently ‘‘matured’’ DCs failed to support
a productive (auto)immune response involving T cell infiltration
and destruction of pancreatic islets leading to diabetes. Because
of these important contributions to the diabetogenic process,
blockade of the IL-21-IL-21R interaction, especially in conjunc-
tion with other therapies such as T cell ablation or active induc-
tion of Ag-specific regulation, could contribute to strategies for
the prevention or maybe even reversal of T1D.
EXPERIMENTAL PROCEDURES
Mice and Diabetes Induction
Il21r/ NOD mice were described (Sutherland et al., 2009) and bred to
Ins-LCMV-NP NOD (NOD-NP) mice (Martinic et al., 2007) to obtain Il21r/
NOD-NP mice. All mice were housed in microisolator cages under specific-
pathogen-free conditions at the La Jolla Institute for Allergy and Immunology
(LIAI). All animal studies were performed according to institutional and NIH
guidelines for animal use and care and with the permission from the
Institutional Animal Care and Use Committee (IACUC). Additional information
is provided in Supplemental Information.
In Vivo Treatments
Anti-CD40 (FGK45, kindly provided by S. Schoenberger) was administered as
100 mg mAb in 100 ml PBS by retro-orbital i.v. CD4+ T cell depletion by 250 mg
anti-CD4 i.v. (GK1.5) on days 3, 1, and +1 a.i. Cyclophosphamide (CY)
treatment consisted of 200 mg/kg CY in 0.9% saline solution twice with
a 2-week interval (Brode et al., 2006). Multiple low-dose streptozotocin (STZ)
diabetes induction was done according to the AMDCC protocol on mice
fasted for 4 hr prior to treatment (5 daily i.p. doses of 50 mg/kg STZ prepared
freshly in Na-citrate solution [pH 4.5]) and followed by provision of 10%
sucrose drinking solution.
Intrapancreatic Injection
Alexa Fluor 594-labeled ovalbumin (AF594-OVA, 200 mg/adult mouse in 100 ml
PBS maximum) was injected in the pancreas, as explained in Turley et al.
(2003) and in the Supplemental Information.
T Cell Isolation
CD4+CD25 T cells were negatively selected by depletion of CD8+ (53-6.7),
CD25+ (7D4), B220+, CD11c+, CD11b+, MHC class II+, CD49b+, and
TER119+ cells via purified antibodies and sheep anti-rat IgG Dynabeads
(Invitrogen). CD8+ T cells were isolated by depletion of CD4+ (RM-4.5),
B220+, CD11c+, CD11b+, MHC class II+, CD49b+, and TER119+ cells. For
suppression assays, CD4+CD25+ cells were isolated in two steps: a negative
selection of CD4+ T cells, followed by positive selection of CD25+ cells
(CD25microbead kit, Miltenyi Biotec). CFSE labeling entailed two PBSwashes
prior to CFSE incubation (1 mM for in vitro, 2.5 mM for in vivo assays) for
12 min at 37C and was stopped with an equal volume of ice-cold FCS and
washed in T cell medium.
DC Isolation
Spleen and/or pancreatic LN were processed and incubated with frequent
agitation in collagenase D for 2 3 20 min at 37C, followed by red blood cell
lysis for spleen samples. Next, T, B, and NK cells were depleted by purified
antibodies to CD90, CD19, and CD49b (DX5) and sheep anti-rat IgG Dyna-
beads (Invitrogen). The remaining fraction was then enriched by positive
selection of CD11c+ DCs by using CD11cMACSmicrobeads (Miltenyi Biotec),
according to the manufacturer’s instructions.
Endocytosis Assay
Assay was done as published (Turley et al., 2003; Vermaelen et al., 2001) and
explained in the Supplemental Information.Insulitis Scores
Pancreatic sections (6 mm)were fixed and incubatedwith primary antibodies to
insulin and CD4 or CD8 and with enzyme-linked secondary antibodies prior to
visualization with substrates, as detailed in the Supplemental Information.
Helpless Assay
The assay was done as published (Janssen et al., 2003) and explained in the
Supplemental Information.
Flow Cytometry
Fluorochrome-labeled monoclonal antibodies were from BD Biosciences,
eBioscience, or BioLegend, as documented in detail in the Supplemental
Information. Incubation with Fc block (CD16/32; 1 mg/ml for 10 min at RT)
preceded each staining. Foxp3 staining was performed with eBioscience
reagents. BDC2.5 CD4+ T cells were detected with APC-conjugated I-A(g7)
tetramer with BDC2.5 sequence 2 (RTRPLWVRME; NIAID tetramer facility)
for 30 min at room temperature. Staining for CCR7 was done with PE-Clone
4B1 (eBioscience) for 30min at 37C. Np396-404/Db or gp33-41/Db pentamer
staining was done for 30min at RT (7.5 ml/sample, ProImmune). LCMV-specific
CD8+ T cell responses were also measured by restimulation in vitro for 5 hr
with 0.2 mg/ml np396-404 or gp33-41 peptide, T cell-depleted splenocytes
(TdS, from naive NOD), and 10 mg/ml Brefeldin A, but without added IL-2,
followed by intracellular staining for IFN-g, tumor necrosis factor-a (TNF-a),
or IL-2. When pentamer staining and intracellular cytokine staining (ICS)
were combined, pentamer and surface staining preceded the restimulation
for ICS. CD107a (LAMP-1) staining was done as published (Betts et al.,
2003). In brief, cells were stimulated with 1 mg/ml np396-404 peptide for 4 hr
in the presence of AF448-conjugated CD107a mAb (1:200) and monensin
(eBioscience, 1:1000), then stained for cell subset markers. Exclusion of
dead cells was done via the Live Dead kit (Aqua or Violet, Invitrogen),
according to the manufacturer’s instructions. Stained samples were acquired
on LSRII and analyzed with FlowJo.
Statistical Analysis
For diabetes incidence, statistical significance was calculated by log rank test
(Mantel-Cox). For cell subset analysis, nonparametric t test Mann-Whitney
was used. Statistical significance is indicated as follows: ns, not significant;
*p < 0.05, **p < 0.01, ***p < 0.001. Red error bars represent means ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at doi:10.1016/
j.immuni.2012.04.005.
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